SCHEMBL20049318

SCHEMBL20049318

CCc1ccc2cc(C(C)C)cnc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.43
▸ AKR1C2 P52895 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2A6 P11509 1/20 0.43
▸ ELANE P08246 2/20 0.37
▸ NPC1 O15118 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ MAOB P27338 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14086327 0.87 AKR1C3 (0.43) AKR1C3AKR1C2CYP1A2CYP2A6ELANE
SCHEMBL20178504 0.85 ABL1 (0.39) AKR1C3AKR1C2NPC1RAB9ANFKB1
SCHEMBL803417 0.80 CYP1A2 (0.50) AKR1C3AKR1C2CYP1A2CYP2A6ELANE
SCHEMBL11322091 0.80 OGA (0.40) CYP1A2NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL7994356 0.80 GAA (0.44) AKR1C3AKR1C2MEN1ALDH1A1KMT2A
SCHEMBL20049323 0.80 AKR1C3 (0.40) AKR1C3AKR1C2CYP1A2CYP2A6NPC1
SCHEMBL22956861 0.79 PIK3CD (0.41) AKR1C3AKR1C2CYP1A2CYP2A6NPC1
SCHEMBL22134831 0.79 CYP1A2 (0.42) AKR1C3AKR1C2CYP1A2CYP2A6ELANE
SCHEMBL23906417 0.77 CYP1A2 (0.53) CYP1A2CYP2A6ELANENPC1RAB9A
SCHEMBL2667927 0.77 ALDH1A1 (0.47) CYP1A2CYP2A6ALDH1A1KMT2APDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018067704-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. (US) 2018-04-12 — — WO disclosed
Send feedback